Results 221 to 230 of about 551,941 (324)

Mechanisms of homotypic lymphocyte aggregation and cell motility characteristics induced by activation of VLA integrins

, 1995
Sriram Neelamegham
openalex   +1 more source

Diffusion Spectrum Imaging Maps Early Axonal Loss and a Unique Progressive Signal in Neuronal Intranuclear Inclusion Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To delineate specific in vivo white matter pathology in neuronal intranuclear inclusion disease (NIID) using diffusion spectrum imaging (DSI) and define its clinical relevance. Methods DSI was performed on 42 NIID patients and 38 matched controls.
Kaiyan Jiang, Yixiu Pei, Xiaobao Hu, Ying Xiong, Fang Wang, Yanyan Yu, Min Zhu, Dandan Tan, Meihong Zhou, Daojun Hong, Fuqing Zhou   +10 more
wiley   +1 more source

ROS-Driven PKCζ Signaling as a Widely Involved Mechanism for Cancer Cell Motility and Metastasis. [PDF]

Cancer Sci
Sato Y, Tanaka M, Kitamura N, Araki N, Kurata W, Sasaki A, Seo Y, Kuribayashi K, Kobayashi S, Niitsu Y.   +9 more
europepmc   +1 more source

Engulfment and cell motility 1 (ELMO1) and apolipoprotein A1 (APOA1) as candidate genes for sickle cell nephropathy

, 2020
Santosh L. Saraf, Xu Zhang, Binal N. Shah, Rasha Raslan, Bamidele O. Tayo, James P. Lash, Nora Franceschini, Victor R. Gordeuk   +7 more
openalex   +2 more sources

Wnt-Dependent T-Cell Factor-4 Controls Human Etravillous Trophoblast Motility [PDF]

, 2014
Gudrun Meinhardt, Sandra Haider, Peter Haslinger, Katharina Proestling, Christian Fiala, Jürgen Pollheimer, Martin Knöfler   +6 more
openalex   +1 more source

Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Identifying objective biomarkers for progressive supranuclear palsy (PSP) is crucial to improving diagnosis and establishing clinical trial and treatment endpoints. This study evaluated fluid biomarkers in PSP versus controls and their associations with regional 18F‐PI‐2620 tau‐PET, clinical, and cognitive outcomes.
Roxane Dilcher, Charles B. Malpas, Stuart J. McDonald, William T. O’Brien, Craig Despott, Kelly L. Bertram, Matthew P. Pase, Lukas Frontzkowski, Meng Law, Terence J. O’Brien, Lucy Vivash   +10 more
wiley   +1 more source

Design rules for adhesion-driven synthetic cell motility on dynamic membranes. [PDF]

Chem Sci
Di Iorio D, Heidari A, Wegner SV.
europepmc   +1 more source

Referee report. For: Cell motility influences microfluidics capturing in scRNA-seq [version 1; peer review: 1 approved with reservations]

Carolina Moura Costa Catta Preta
openalex   +1 more source

Functional and Structural Evidence of Neurofluid Circuit Aberrations in Huntington Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Disrupted neurofluid regulation may contribute to neurodegeneration in Huntington disease (HD). Because neurofluid pathways influence waste clearance, inflammation, and the distribution of central nervous system (CNS)–delivered therapeutics, understanding their dysfunction is increasingly important as targeted treatments emerge.
Kilian Hett, Abigail Dubois, Melanie Leguizamon, Alexander Song, Paula Trujillo, Colin D. McKnight, Ciaran M. Considine, Manus J. Donahue, Daniel O. Claassen   +8 more
wiley   +1 more source

Altering the biophysical properties of ERC1/ELKS-driven condensates interferes with cell motility. [PDF]

Commun Biol
Ribolla LM, Patrone M, Degano M, Ramella M, de Curtis I.   +4 more
europepmc   +1 more source